QuantiFERON-TB Gold Plus

The Florida Department of Health (FDOH), Palm Beach County Laboratory, is seeking to purchase reagents and supplies to perform Mycobacterium tuberculosis specific antigen testing using the QuantiFERON-TB Gold Plus, an Interferon Gamma Release Assay (IGRA). The testing is critical to identifying individuals in Palm Beach County who have been infected with Mycobacterium tuberculosis and is used for testing outreach conducted by the County Health Department's Tuberculosis Program. FDOH, Palm Beach County is requesting authorization to purchase the test kits and collection devices as a single source from Qiagen, LLC, the sole manufacturer and distributor of the FDA-approved products required for the testing instrumentation currently owned by the agency. The total estimated price for the single source contract is $300,000, and the contract is necessary to maintain continuity of the specialized testing required by the agency to serve the clients in Palm Beach County and identify possible tuberculosis outbreaks. The due date for this contract opportunity is May 23, 2022.

The contract opportunity is designated as a single source procurement, as Qiagen, LLC is the sole manufacturer and distributor of the necessary reagents and collection devices required for the testing instrumentation currently owned by the FDOH, Palm Beach County Laboratory. There are no set-aside designations or restrictions on the types of organizations that can respond, as Qiagen, LLC is the only qualified vendor for this specialized testing. The current contract value is estimated at $300,000.